Opportunity Information: Apply for RFA AG 13 012
Apply for RFA AG 13 012
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Paul B. Beeson Patient Oriented Research Career Development Award in Aging (K23)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.866 Aging Research.
- This funding opportunity was created on Oct 19, 2012 and posted on Oct 3, 2012.
- Applicants must submit their applications by Dec 6, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,000,000.00 to eligible and selected applicants.
- Eligible applicants include: Public and State controlled institutions of higher education Private institutions of higher education City or township governments Small businesses County governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Paul B. Beeson Patient-Oriented Research Career Development Award in Aging (K23) is a National Institutes of Health (NIH) career development grant led by the National Institute on Aging (NIA), with additional support coming from the John A. Hartford Foundation and the American Federation for Aging Research (AFAR). Its central purpose is to build the next generation of leaders in aging research by helping clinically trained early-career faculty, most often physicians, get the protected time, mentoring, and structured research training they need to become independent investigators. The award is specifically oriented toward patient-focused research, meaning work that directly involves human participants or uses clinical data and interactions in ways that clearly connect to improving health and care for older adults.
This opportunity was offered as a discretionary grant mechanism under the NIH K23 framework, which is designed for clinicians who want to deepen their research skills and establish a long-term, independent research program. In practice, the Beeson K23 is meant to move a promising clinician from the early faculty stage into a position where they can compete successfully for major independent NIH research funding and lead impactful projects in geriatrics, gerontology, and aging-related clinical science. The program’s emphasis is not only on conducting a specific research project, but also on building a clear career development plan, supported by strong mentorship, that results in the applicant becoming a recognized contributor in aging research.
The announcement (Funding Opportunity Number RFA-AG-13-012) was posted in early October 2012, with an application deadline of December 6, 2012, and an archived date of January 6, 2013. The estimated total funding amount listed for the opportunity was $1,000,000, and there was no cost sharing or matching requirement, which means applicants were not required to provide institutional or other non-federal matching funds as a condition of the award (though institutions typically provide commitments like protected time or resources as part of career development proposals). The activity falls under health-related funding categories and is associated with CFDA numbers 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders) and 93.866 (Aging Research), reflecting the broad relevance of aging science across clinical and neurological domains.
Eligibility to apply was broad at the institutional level and included many types of U.S.-based organizations, such as public and private institutions of higher education, nonprofit organizations with or without 501(c)(3) status (as applicable), state and local governments, tribal governments and tribal organizations, public housing authorities, independent school districts, regional organizations, and certain for-profit entities (including small businesses, and other for-profit organizations as specified). The eligibility list explicitly included institutions that serve specific populations, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and faith-based or community-based organizations. At the same time, the opportunity clearly restricted foreign involvement: non-U.S. (foreign) institutions were not eligible to apply, non-U.S. components of U.S. organizations were not eligible, and foreign components (as defined by NIH policy) were not allowed. In other words, applications had to be fully domestic in organizational structure and project execution.
Operationally, this funding opportunity sits within the NIH’s broader strategy to strengthen the aging research workforce by investing in clinician-scientists at a point when career trajectory can be strongly shaped by mentored research time and formal development. By combining NIA leadership with contributions from the Hartford Foundation and AFAR, the Beeson program signals a strong commitment from both federal and philanthropic partners to expand the number of independent investigators who can advance patient-oriented research that improves health outcomes, healthcare delivery, and quality of life for older adults. Applicants seeking the full official requirements and instructions were directed to the NIH Grants Guide link provided in the announcement, with NIH Office of Extramural Research (OER) webmaster contacts listed for access or technical issues.
Frequently Asked Questions (FAQs): Paul B. Beeson Patient-Oriented Research Career Development Award in Aging (K23)
What is the Paul B. Beeson Patient-Oriented Research Career Development Award in Aging (K23)?
The Paul B. Beeson Patient-Oriented Research Career Development Award in Aging (K23) is an NIH career development grant under the K23 framework. It is led by the National Institute on Aging (NIA) with additional support from the John A. Hartford Foundation and the American Federation for Aging Research (AFAR). The program is designed to help clinically trained early-career faculty build the skills, mentorship, and research foundation needed to become independent investigators in aging-related, patient-oriented research.
What is the main goal of the Beeson K23 award?
The central purpose is to build the next generation of leaders in aging research. The award is intended to provide protected time, structured research training, and strong mentoring so that a promising clinician can progress from early faculty stage to independence and competitiveness for major NIH research funding.
What does "patient-oriented research" mean in this program?
In this opportunity, patient-oriented research refers to research that directly involves human participants or uses clinical data and interactions in ways that clearly connect to improving health and care for older adults. The emphasis is on work that is closely tied to real-world clinical care and outcomes for aging populations.
What type of applicant is this award designed for?
This opportunity targets clinically trained early-career faculty, most often physicians, who want to deepen their research skills through a mentored career development award and establish a long-term, independent research program focused on aging.
Is the Beeson K23 focused only on a single research project?
No. While applicants propose a specific patient-oriented research project, the program also places strong weight on a clear career development plan and a structured mentoring and training approach. The intent is career progression toward independence, not only completion of one project.
Which NIH mechanism does this opportunity use?
This Beeson award was offered as a discretionary grant mechanism under the NIH K23 framework, which supports mentored patient-oriented research career development for clinicians.
Who leads and supports this funding opportunity?
The National Institute on Aging (NIA) leads the program. Additional support is provided by the John A. Hartford Foundation and the American Federation for Aging Research (AFAR), reflecting both federal and philanthropic commitment to developing aging research leaders.
What is the Funding Opportunity Number (FON) for this announcement?
The Funding Opportunity Number provided in the announcement is RFA-AG-13-012.
When was this funding opportunity posted and when was the application due?
The announcement was posted in early October 2012. The application deadline was December 6, 2012.
Is this funding opportunity still open?
No. The opportunity is listed as archived, with an archived date of January 6, 2013.
How much total funding was estimated for this opportunity?
The estimated total funding amount listed for the opportunity was $1,000,000.
Was cost sharing or matching required?
No. The announcement stated there was no cost sharing or matching requirement, meaning applicants were not required to provide institutional or other non-federal matching funds as a condition of the award.
If no matching is required, does the institution still need to show commitment?
The announcement notes that, even without a formal cost share requirement, institutions typically provide commitments such as protected time or resources as part of career development proposals.
What are the main research areas or categories associated with this award?
The opportunity falls under health-related funding categories and is tied to aging-focused clinical science. It is associated with CFDA numbers that reflect aging research and broader relevance across clinical and neurological domains.
Which CFDA numbers are associated with this opportunity?
The announcement lists CFDA 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders) and CFDA 93.866 (Aging Research).
What kinds of organizations were eligible to apply?
Eligibility at the institutional level was broad and included many U.S.-based organizations such as public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status, as applicable), state and local governments, tribal governments and tribal organizations, public housing authorities, independent school districts, regional organizations, and certain for-profit entities (including small businesses and other for-profit organizations as specified).
Were institutions serving specific populations explicitly included?
Yes. The eligibility list explicitly included organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and faith-based or community-based organizations.
Are foreign institutions eligible to apply?
No. Non-U.S. (foreign) institutions were not eligible to apply under this opportunity.
Can a U.S. organization include a non-U.S. component in its application?
No. The announcement states that non-U.S. components of U.S. organizations were not eligible, and foreign components (as defined by NIH policy) were not allowed. Applications had to be fully domestic in organizational structure and project execution.
What career stage is this program meant to support?
The program is intended to support a clinician-scientist at the early faculty stage, when protected time and mentored research training can strongly shape long-term career trajectory toward becoming an independent investigator in aging research.
What outcomes is the Beeson K23 intended to produce?
The award is meant to position the recipient to compete successfully for major independent NIH research funding and to lead impactful projects in geriatrics, gerontology, and aging-related clinical science. It emphasizes becoming a recognized contributor in aging research through mentored development.
Where were applicants directed for official instructions and requirements?
Applicants seeking full official requirements and instructions were directed to the NIH Grants Guide link provided in the announcement.
Who was listed for help with access or technical issues?
The announcement referenced NIH Office of Extramural Research (OER) webmaster contacts for access or technical issues.
Browse more opportunities from the same category: Health
Next opportunity: DOD FY12 Breast Cancer Research Program Postdoctoral Fellowship Award
Previous opportunity: Paul B. Beeson Clinical Scientist Development Award in Aging (K08)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 13 012
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 13 012) also looked into and applied for these:
| Funding Opportunity |
|---|
| Epigenetic Inheritance and Transgenerational Effects of Alcohol (R01) Apply for PA 13 003 Funding Number: PA 13 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epigenetic Inheritance and Transgenerational Effects of Alcohol (R21) Apply for PA 13 004 Funding Number: PA 13 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Limited Competition Continuation of the National Institute on Aging Multicenter Clinical Trial The LIFE Study (U01) Apply for PAR 13 001 Funding Number: PAR 13 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| TECHNICAL ASSISTANCE AND SUPPORT OF HIV PREVENTION, CARE TREATMENT PROGRAMS AND OTHER INFECTIOUS DISEASES THAT IMPACT HIV INFECTED PATIENTS IN SUPPORT OF THE PRESIDENTS EMERGENCY PLAN FOR AIDS RELIEF Apply for CDC RFA PS09 9040401SUPP13 Funding Number: CDC RFA PS09 9040401SUPP13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $635,768 |
| Presidents Malaria Initiative Apply for USAID GUINEA RFA 675 13 000001 Funding Number: USAID GUINEA RFA 675 13 000001 Agency: Senegal USAID Dakar Category: Health Funding Amount: $18,428,129 |
| Interdisciplinary Approach to Identification and Validation of Novel Therapeutic Targets for Alzheimers Disease (R01) Apply for RFA AG 13 013 Funding Number: RFA AG 13 013 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Alzheimers Disease Prevention Trials (R01) Apply for RFA AG 13 015 Funding Number: RFA AG 13 015 Agency: National Institutes of Health Category: Health Funding Amount: $4,500,000 |
| Alzheimers Disease Phase I Clinical Trials (R01) Apply for RFA AG 13 016 Funding Number: RFA AG 13 016 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Shared Instrumentation Grant Program (S10) Apply for PAR 13 008 Funding Number: PAR 13 008 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Dynamics of Host Associated Microbial Communities (R01) Apply for RFA GM 14 001 Funding Number: RFA GM 14 001 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Secondary Dataset Analyses in Heart, Lung, and Blood Diseases and Sleep Disorders (R21) Apply for PAR 13 009 Funding Number: PAR 13 009 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Mentored Research Scientist Development Award in Metabolomics (K01) Apply for RFA RM 12 025 Funding Number: RFA RM 12 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health System Strengthening Project Apply for APS 391 13 000001 Funding Number: APS 391 13 000001 Agency: Pakistan USAID Islamabad Category: Health Funding Amount: $21,900,000 |
| Limited Competition Brain Tissue Resource Center for Alcohol Research (R28) Apply for PAR 13 011 Funding Number: PAR 13 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Initiative to Maximize Research Education in Genomics Courses (R25) Apply for PAR 13 012 Funding Number: PAR 13 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Agir pour la Planification Familiale AGIR PF Apply for RFA 624 13 000002 Funding Number: RFA 624 13 000002 Agency: Ghana USAID Accra Category: Health Funding Amount: $29,000,000 |
| Alzheimers Disease Therapeutics Program (U01) Apply for RFA AG 13 014 Funding Number: RFA AG 13 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epigenomics of Virus Associated Oral Diseases (R21) Apply for RFA DE 13 003 Funding Number: RFA DE 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Epigenomics of Virus Associated Oral Diseases (R01) Apply for RFA DE 13 002 Funding Number: RFA DE 13 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Network for Clinical Research on Immune Tolerance (UM1) Apply for RFA AI 12 043 Funding Number: RFA AI 12 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 13 012", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.